1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Asia Pacific PoC Diagnostics Market Analysis And Segment Forecasts To 2020

The Asia Pacific market for point of care (PoC) diagnostics is expected to reach USD 5,427.1 million by 2020. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expected to be key market factors.

The rapidly growing use of point of care diagnostic products has introduced a decentralization trend in the overall healthcare industry. Healthcare facilities and patients, in an attempt to attain or cater medical facilities remotely, encourage early diagnosis and curb costs are now decentralizing their facilities. Furthermore, these trends have also triggered the establishment of remote and stand alone diagnostic facilities.

Further Key findings from the study suggest:

Glucose testing segment dominated the market in 2013, accounting for over 29% of total revenue. High prevalence of diabetes coupled with the requirement of constant monitoring of blood sugar levels attribute to the aforementioned fact. According to statistics published by the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 382 million in 2013 to 592 million in 2035, which is expected to have a positive impact on glucose testing demand.

The infectious disease testing is expected to be the fastest growing product segment, at an estimated CAGR of 16.2% from 2014 to 2020 with projected market revenue of USD 478.50 million in 2020.
Hospitals and clinics together constitute the largest revenue share of the Asia Pacific PoC market. Large volume of diagnostic tests performed in these healthcare facilities and the growing demand for decentralized point of care diagnostic facilities are two of the most important factors attributing to their large market shares. Clinics based PoC diagnostics market was valued at USD 1,104.51 million in 2013.

Japan dominated the Asia Pacific market in 2013, accounting for over 48% of total market revenue. However, the region is expected to lose market share by 2020, primarily due to faster growing markets such as India, Malaysia, Indonesia and China. China followed Japan in terms of revenue share in 2013 owing to the presence of high unmet medical needs coupled with constantly improving healthcare infrastructure.
Some of the key players of the Asia Pacific PoC diagnostics market include Roche Diagnostics, Alere Inc., Danaher Corporation, Abbott Laboratories, bioMerieux, Siemens Healthcare and others.

For the purpose of this study, Grand View Research has segmented the Asia Pacific PoC diagnostics market on the basis of product, application and region:

- Asia Pacific PoC Diagnostics Product Outlook
- Blood Gas/Electrolytes
- Infectious Diseases
- Glucose Testing
- Cardiac Markers
- Hematology
- Coagulation
- Primary Care Systems (Includes Lipid and Hba1c tests)
- Decentralized Clinical Chemistry
- Urinalysis
- Drug Abuse Testing
- Fertility
- OTC Diagnostics and Rapid Tests
- Feces
- Asia Pacific PoC Diagnostics End-User Outlook
- Hospitals
- Laboratories
- Assisted Living Healthcare Facilities
- Home Healthcare
- Clinics
- Others
- Asia Pacific PoC Diagnostics Regional Outlook
- India
- Japan
- China
- Taiwan
- Philippines
- South Korea
- Malaysia
- Singapore
- Indonesia
- Australia
- New Zealand
- Hong Kong
- Vietnam
- Pakistan
- Thailand
- Rest of Asia Pacific

Table Of Contents

Asia Pacific PoC Diagnostics Market Analysis And Segment Forecasts To 2020
Table of Contents

Chapter 1. Executive Summary

1.1. Asia Pacific PoC Diagnostics - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Asia Pacific PoC Diagnostics Industry Outlook

2.1. Market Segmentation

2.2. Market Size and Growth Prospects

2.3. Asia Pacific PoC Diagnostics Market Dynamics

2.3.1. Market Driver Analysis

2.3.2. Impact Analysis of Market Drivers

2.3.3. Market Restraint Analysis

2.3.4. Impact Analysis of Market Restraints

2.4. Key Opportunities Prioritized

2.5. Industry Analysis - Porter's

2.6. Asia Pacific PoC Diagnostics - Company Market Share Analysis

2.7. Asia Pacific PoC Diagnostics Market PESTEL Analysis, 2012

Chapter 3. Asia Pacific PoC Diagnostics Product Outlook

3.1. Blood Gas/Electrolytes Market

3.1.1. Blood Gas/Electrolytes Market, (USD Million), 2012 - 2020

3.2. Infectious Disease Testing Market

3.2.1. Infectious Disease Testing Market, (USD Million), 2012 - 2020

3.3. Glucose Testing Market

3.3.1. Glucose Testing Market, (USD Million), 2012 - 2020

3.4. Cardiac Markers Market

3.4.1. Cardiac Markers Market, (USD Million), 2012 - 2020

3.5. Hematology Market

3.5.1. Hematology Market, (USD Million), 2012 - 2020

3.6. Coagulation Market

3.6.1. Coagulation Market, (USD Million), 2012 - 2020

3.7. Primary Care Systems (Lipid Profiling and HbA1C Tests) Market

3.7.1. Primary Care Systems (Lipid Profiling and HbA1C Tests) Market, (USD Million), 2012 - 2020

3.8. Decentralized Clinical Chemistry Market

3.8.1. Decentralized Clinical Chemistry Market, (USD Million), 2012 - 2020

3.9. Urinalysis Market

3.9.1. Urinalysis Market, (USD Million), 2012 - 2020

3.10. Drug Abuse Testing Market

3.10.1. Drug Abuse Testing Market, (USD Million), 2012 - 2020

3.11. Fertility Market

3.11.1. Fertility Market, (USD Million), 2012 - 2020

3.12. OTC and Rapid Diagnostic Tests Market

3.12.1. OTC and Rapid Diagnostic Tests Market, (USD Million), 2012 - 2020

3.13. Feces Testing Market

3.13.1. Feces Testing Market, (USD Million), 2012 - 2020

Chapter 4. Asia Pacific PoC Diagnostics End-Use Outlook

4.1. Hospitals

4.1.1. PoC Diagnostics Based Hospitals Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.2. Laboratory

4.2.1. PoC Diagnostics Based Laboratory Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.3. Assisted Living Healthcare Facilities

4.3.1. Assisted Living Healthcare Facilities Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.4. Home Healthcare

4.4.1. PoC Diagnostics Based Home Healthcare Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.5. Clinics

4.5.1. PoC Diagnostics Based Clinics Market Estimates and Forecasts, 2012 - 2020 (USD Million)

4.6. Other Facilities

4.6.1. PoC Diagnostics Based Other Facilities Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 5. Asia Pacific PoC Diagnostics Regional Outlook

5.1. India

5.1.1. India PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.1.2. India PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.2. Japan

5.2.1. Japan PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.2.2. Japan PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.3. China

5.3.1. China PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.3.2. China PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.4. Taiwan

5.4.1. Taiwan PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.4.2. Taiwan PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.5. Philippines

5.5.1. Philippines PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.5.2. Philippines PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.6. South Korea

5.6.1. South Korea PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.6.2. South Korea PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.7. Malaysia

5.7.1. Malaysia PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.7.2. Malaysia PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.8. Singapore

5.8.1. Singapore PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.8.2. Singapore PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.9. Indonesia

5.9.1. Indonesia PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.9.2. Indonesia PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.10. Australia

5.10.1. Australia PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.10.2. Australia PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.11. New Zealand

5.11.1. New Zealand PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.11.2. New Zealand PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.12. Thailand

5.12.1. Thailand PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.12.2. Thailand PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.13. Hong Kong

5.13.1. Hong Kong PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.13.2. Hong Kong PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.14. Vietnam

5.14.1. Vietnam PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.14.2. Vietnam PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.15. Pakistan

5.15.1. Pakistan PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.15.2. Pakistan PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

5.16. Rest of Asia Pacific

5.16.1. Rest of Asia Pacific PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

5.16.2. Rest of Asia Pacific PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)

Chapter 6 Competitive Landscape

6.1 Roche Diagnostics

6.1.1 Company Overview

6.1.2 Financial Performance

6.1.3 Product Benchmarking

6.1.4 Strategic Initiatives

6.2 Abbott Laboratories

6.2.1 Company Overview

6.2.2 Financial Performance

6.2.3 Product Benchmarking

6.2.4 Strategic Initiatives

6.3 Alere Inc.

6.3.1 Company Overview

6.3.2 Financial Performance

6.3.3 Product Benchmarking

6.3.4 Strategic Initiatives

6.4 Siemens Healthcare

6.4.1 Company Overview

6.4.2 Financial Performance

6.4.3 Product Benchmarking

6.4.4 Strategic Initiatives

6.5 Danaher Corporation

6.5.1 Company Overview

6.5.2 Financial Performance

6.5.3 Product Benchmarking

6.5.4 Strategic Initiatives

6.6 BD

6.6.1 Company Overview

6.6.2 Financial Performance

6.6.3 Product Benchmarking

6.6.4 Strategic Initiatives

6.7 Abaxis Inc.

6.7.1 Company Overview

6.7.2 Financial Performance

6.7.3 Product Benchmarking

6.7.4 Strategic Initiatives

6.8 Nova Biomedical

6.8.1 Company Overview

6.8.2 Financial Performance

6.8.3 Product Benchmarking

6.8.4 Strategic Initiatives

6.9 Instrumentation Laboratory

6.9.1 Company Overview

6.9.2 Financial Performance

6.9.3 Product Benchmarking

6.9.4 Strategic Initiatives

6.10 Sysmex

6.10.1 Company Overview

6.10.2 Financial Performance

6.10.3 Product Benchmarking

6.10.4 Strategic Initiatives

6.11 Johnson and Johnson

6.11.1 Company Overview

6.11.2 Financial Performance

6.11.3 Product Benchmarking

6.11.4 Strategic Initiatives

6.12 Radiometer

6.12.1 Company Overview

6.12.2 Financial Performance

6.12.3 Product Benchmarking

6.12.4 Strategic Initiatives

6.13 Qiagen

6.13.1 Company Overview

6.13.2 Financial Performance

6.13.3 Product Benchmarking

6.13.4 Strategic Initiatives

6.14 Spectral Diagnostics

6.14.1 Company Overview

6.14.2 Financial Performance

6.14.3 Product Benchmarking

6.14.4 Strategic Initiatives

6.15 OraSure

6.15.1 Company Overview

6.15.2 Financial Performance

6.15.3 Product Benchmarking

6.15.4 Strategic Initiatives

6.16 Quidel Corporation

6.16.1 Company Overview

6.16.2 Financial Performance

6.16.3 Product Benchmarking

6.16.4 Strategic Initiatives

6.17 Sekisui Diagnostics

6.17.1 Company Overview

6.17.2 Financial Performance

6.17.3 Product Benchmarking

6.17.4 Strategic Initiatives



Chapter 7. Methodology and Scope

7.1. Research Methodology

7.2. Research Scope and Assumption

7.3. List of Data Sources


List of Tables

Asia Pacific PoC Diagnostics - Industry summary and Critical Success Factors (CSFs)
Asia Pacific PoC market revenue, 2012 - 2020 (USD million)
Asia Pacific PoC market revenue, by products, 2012 - 2020 (USD million)
Asia Pacific PoC market revenue, by end user, 2012 - 2020 (USD million)
Asia Pacific PoC market revenue, by country, 2012 - 2020 (USD million)
Asia Pacific PoC diagnostics - Key market driver analysis
Diabetes prevalence, top 10 countries, 2013
Asia Pacific PoC Diagnostics - Key market restraint analysis
Asia Pacific PoC glucose testing revenue, 2012-2020, (USD Million)
Asia Pacific point of care OTC and rapid diagnostic tests revenue, 2012-2020 (USD million)
Asia Pacific point of care cardiac markers revenue, 2012-2020 (USD million)
Asia Pacific point of care fertility diagnostics revenue, 2012-2020 (USD million)
Asia Pacific point of care blood gas and electrolytes diagnostics revenue, 2012-2020 (USD million)
Asia Pacific point of care decentralized clinical chemistry diagnostics revenue, 2012-2020 (USD million)
Asia Pacific point of care infectious disease testing revenue, 2012-2020 (USD million)
Asia Pacific point of care coagulation diagnostics revenue, 2012-2020 (USD million)
Asia Pacific point of care primary care systems revenue, 2012-2020 (USD million)
Asia Pacific point of care hematology diagnostics revenue, 2012-2020 (USD million)
Asia Pacific point of care urinalysis diagnostics revenue, 2012-2020 (USD million)
Asia Pacific point of care drug abuse testing revenue, 2012-2020 (USD million)
Asia Pacific point of care feces testing revenue, 2012-2020 (USD million)
Japan PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Japan PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Australia PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Australia PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
China PoC diagnostics revenue, by products, 2012 - 2020 (USD million) 59
China PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
India PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
India PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Thailand PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Thailand PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
South Korea PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
South Korea PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
New Zealand PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
New Zealand PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Singapore PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Singapore PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Hong Kong PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Hong Kong PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Philippines PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Philippines PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Taiwan PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Taiwan PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Malaysia PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Malaysia PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Vietnam PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Vietnam PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Pakistan PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Pakistan PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Indonesia PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Indonesia PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
Rest of Asia Pacific PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
Rest of Asia Pacific PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)

List of Figures

Asia Pacific PoC Diagnostics: Market Segmentation
Asia Pacific PoC Diagnostics Market Revenue, 2012 - 2020 (USD million)
Asia Pacific PoC Diagnostics Market Dynamics
Global percentage of population, by age group, 2000 and 2050
Regional breakdown of population over the age of 65 years, by region, 2010 and 2050
Asia Pacific PoC diagnostics revenue share by product, 2012 and 2020
Asia Pacific PoC diagnostics revenue share by country, 2012 and 2020
Japan PoC diagnostics revenue, 2012 - 2020 (USD million)
Australia PoC diagnostics revenue, 2012 - 2020 (USD million)
Australia blood gas and electrolytes company market share analysis, 2013
Australia decentralized clinical chemistry company market share analysis, 2013
Australia infectious disease testing company market share analysis, 2013
Australia hematology company market share analysis, 2013
Australia: coagulation company market share analysis, 2013
Australia OTC and rapid diagnostics company market share analysis, 2013
Australia cardiac markers company market share analysis, 2013
Australia primary care systems company market share analysis, 2013
Australia urinalysis company market share analysis, 2013
Australia drug abuse testing company market share analysis, 2013
Australia feces testing company market share analysis, 2013
Australia fertility testing company market share analysis, 2013
Australia glucose testing company market share analysis, 2013
China PoC diagnostics revenue, 2012 - 2020 (USD million)
China blood gas and electrolytes company market share analysis, 2013
China decentralized clinical chemistry company market share analysis, 2013
China infectious disease testing company market share analysis, 2013
China hematology company market share analysis, 2013
China coagulation company market share analysis, 2013
China OTC and rapid diagnostics company market share analysis, 2013
China cardiac markers company market share analysis, 2013
China primary care systems company market share analysis, 2013
China urinalysis company market share analysis, 2013
China drug abuse testing company market share analysis, 2013
China feces testing company market share analysis, 2013
China fertility testing company market share analysis, 2013
China glucose testing company market share analysis, 2013
India PoC diagnostics revenue, 2012 - 2020 (USD million)
India blood gas and electrolytes company market share analysis, 2013
India decentralized clinical chemistry company market share analysis, 2013
India infectious disease testing company market share analysis, 2013
India hematology company market share analysis, 2013
India coagulation company market share analysis, 2013
India OTC and rapid diagnostics company market share analysis, 2013
India cardiac markers company market share analysis, 2013
India primary care systems company market share analysis, 2013
India urinalysis company market share analysis, 2013
India drug abuse testing company market share analysis, 2013
India feces testing company market share analysis, 2013 75
India fertility testing company market share analysis, 2013
India glucose testing company market share analysis, 2013
Thailand PoC diagnostics revenue, 2012 - 2020 (USD million)
Thailand blood gas and electrolytes company market share analysis, 2013
Thailand decentralized clinical chemistry company market share analysis, 2013
Thailand infectious disease testing company market share analysis, 2013
Thailand hematology company market share analysis, 2013
Thailand coagulation company market share analysis, 2013
Thailand OTC and rapid diagnostics company market share analysis, 2013
Thailand cardiac markers company market share analysis, 2013
Thailand primary care systems company market share analysis, 2013
Thailand urinalysis company market share analysis, 2013
Thailand drug abuse testing company market share analysis, 2013
Thailand feces testing company market share analysis, 2013
Thailand fertility testing company market share analysis, 2013
Thailand glucose testing company market share analysis, 2013
South Korea PoC diagnostics revenue, 2012 - 2020 (USD million)
South Korea blood gas and electrolytes company market share analysis, 2013
South Korea decentralized clinical chemistry company market share analysis, 2013
South Korea infectious disease testing company market share analysis, 2013
South Korea hematology company market share analysis, 2013
South Korea coagulation company market share analysis, 2013
South Korea OTC and rapid diagnostics company market share analysis, 2013
South Korea cardiac markers company market share analysis, 2013
South Korea primary care systems company market share analysis, 2013
South Korea urinalysis company market share analysis, 2013
South Korea drug abuse testing company market share analysis, 2013
South Korea feces testing company market share analysis, 2013
South Korea fertility testing company market share analysis, 2013
South Korea glucose testing company market share analysis, 2013
New Zealand PoC diagnostics revenue, 2012 - 2020 (USD million)
Singapore PoC diagnostics revenue, 2012 - 2020 (USD million) 100
Hong Kong PoC diagnostics revenue, 2012 - 2020 (USD million) 103
Philippines PoC diagnostics revenue, 2012 - 2020 (USD million)
Taiwan PoC diagnostics revenue, 2012 - 2020 (USD million)
Malaysia PoC diagnostics revenue, 2012 - 2020 (USD million)
Vietnam PoC diagnostics revenue, 2012 - 2020 (USD million)
Pakistan PoC diagnostics revenue, 2012 - 2020 (USD million)
Indonesia PoC diagnostics revenue, 2012 - 2020 (USD million)
RoAPAC PoC diagnostics revenue, 2012 - 2020 (USD million)
Asia Pacific PoC diagnostics revenue share by end-user, 2012 and 2020
Asia Pacific PoC diagnostics based hospitals revenue, 2012 - 2020 (USD million)
Asia Pacific PoC diagnostics based clinics revenue, 2012 - 2020 (USD million)
Asia Pacific PoC diagnostics based laboratories revenue, 2012 - 2020 (USD million)
Asia Pacific PoC diagnostics based assisted living healthcare facilities revenue, 2012 - 2020 (USD million)
Asia Pacific PoC diagnostics based home healthcare revenue, 2012 - 2020 (USD million)
Asia Pacific PoC diagnostics based other facilities revenue, 2012 - 2020 (USD million)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.